Belgium· BE-AMP-SAM277575-00

Cefotaxime Teva 500 mg

A cefuroxime product containing cefotaxime sodium, registered in Belgium by Teva Pharma Belgium. The same ATC class is registered in 15 of our 19 countries.

ATC J01DC02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cefotaxime sodiumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cefuroxime is registered in 15 of 19 countries.

Countries holding a registration under ATC J01DC02 (cefuroxime), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search cefuroxime products by name

Cefuroxime · ATC J01DC02

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefuroxime costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.0038 in Finland to $4.41 in Switzerland — a ×1160 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cefuroxime · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

CH Switzerland$4.41
IT Italy$1.06
FI Finland$0.0038

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Cefotaxime Sodium
Manufacturer: Teva Pharma Belgium
Country: Belgium (BE)
ATC code: J01DC02
ATC class: Cefuroxime
Defined daily dose: 0.5 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

210 interactions on record for cefuroxime.

Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cefuroxime against other medicines How interaction checks work

Cefuroxime · interactions on record

210 records

46 moderate
164 info

Most severe, free to view

Magnesium carbonateA02AA01moderate
Magnesium oxideA02AA02moderate
Magnesium hydroxideA02AA04moderate
Kombinationen von AluminiumsalzenA02AB10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefuroxime in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefuroxime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Cefotaxim Aptapharma, Cefotaxim Eberth
Bulgaria · Валоран, Тенатаксим
Cyprus · Oximezin, Syntoxime
Czechia · Cefotaxim Hameln, Cefotaxime Swyssi
Germany · Cefotaxim Eberth, Cefotaxim Fresenius
Denmark · Cefotaxim "hameln", Cefotaxim Mip
Estonia · Cefotaxime Mip, Valoran
Spain · Cefotaxima Normon, Cefotaxima Sala
Finland · Cefotaxim Hameln, Cefotaxim Mip Pharma
France · Cefotaxime Noridem, Cefotaxime Panpharma
United Kingdom (Northern Ireland) · Cefotaxime Cox Pharmaceutical, Cefotaxime Hameln Pharma
Greece · Ciltiren, Gloryfen
Croatia · Cefotaksim Aptapharma, Cefotaksim Mip
Hungary · Cefotaxim Aptapharma, Cefotaxime Swyssi
Ireland · Cefotaxime Hameln, Cefotaxime Noridem Enterprises
Iceland · Cefotaxim Navamedic
Italy · Batixim, Cefotaxim Hameln
Lithuania · Cefotaxime Mip
Luxembourg · Cefotaxime Noridem, Claforan
Latvia · Cefotaxime Mip
Malta · Valoran
Netherlands · Cefotaxim Hameln
Norway · Cefotaxim Hameln, Cefotaxim Mip
Poland · Biotaksym, Cefotaxim Mip
Portugal · Antadar, Antadar I.M.
Romania · Cefotax, Cefotaxim Mip
Sweden · Cefotaxim Hameln, Cefotaxim Mip
Slovenia · Cefotaksim Aptapharma, Valoran
Slovakia · Cefotaxim Eberth, Cefotaxime Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/6e4e124e-9ac5-4212-bf3b-d811f2500078
GET /v1/drugs/6e4e124e-9ac5-4212-bf3b-d811f2500078?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Cefotaxime Teva 500 mg",
  "name_fr": "Cefotaxime Teva 500 mg",
  "name_nl": "Cefotaxime Teva 500 mg",
  "amp_code": "SAM277575-00",
  "strengths": [
    "524.0000",
    "500.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Cefotaxime Sodium",
    "Cefotaxime"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cefuroxime",
  "authorisation_numbers": [
    "BE277575"
  ]
}

API reference MCP server Plans

See everything about cefuroxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console